Harvest One Announces Q2 2019 Financial Results Including a 123% Revenue Increase Over Q1 and Gross Margin of 53% on Cannabis Sales Cannabis Investing News
Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications Pharmaceutical Investing
Canntab Enters into Five Year Supply and Loan Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal Cannabis Investing News
VBL Presents New Data on the Potential of its Novel VB-600 Platform for Nonalcoholic Steatohepatitis (NASH) and Rheumatoid Arthritis (RA) Biotech Investing
